From a regulatory standpoint, this isn't just interesting it's a problem. Agencies evaluate drug products. They don't regulate psychotherapy. If a meaningful, inseparable portion of the treatment effect comes from the therapeutic container rather than the molecule, then defining the independent variable becomes genuinely complicated and your development program needs to address that directly.
-
2 Beiträge
-
1 Fotos
-
0 Videos
-
Lebt in USA
-
Von USA
-
Follower 1 Menschen
© 2026 Soocian
Deutsch
Neueste Updates
-
The Development Alignment GapWhy Clinical Development Programs Fail Before FDA Ever Reviews the Data A Strategic Perspective on Evidence Generation, Regulatory Alignment, and Development Success Denis Katz, MD Founder, Salience Clinical LLC Executive Summary Over the course of my career, I've participated in and advised development programs across pharmaceuticals, biologics, regenerative medicine, diagnostics, neuroscience...0 Kommentare 0 Geteilt 374 Ansichten 0 BewertungenBitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
0 Kommentare 0 Geteilt 175 Ansichten 0 Bewertungen
Mehr Storys